Early Application of Memantine and Pioglitazone to Protect Cognitive Function After Radiotherapy
Early Application of Memantine and Pioglitazone to Protect Cognitive Function After Radiotherapy
Not yet recruiting · NCT06594172 · Registry updated 2024-09-19Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Early Application of Memantine and Pioglitazone to Protect Cognitive Function After Radiotherapy | Cognition Disorders, Cognitive Dysfunction, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, cognitive disorder, injury, psychiatric disorder, radiation injury, radiation-induced disorder | Not yet recruiting | Phase 2 | 2024-09-19 | NCT06594172 |
6 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
0 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| No products are listed yet. | |||